🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
This is a Phase II multi-center trial single arm trial of autologous transp...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2021-10-25
Trial ID
NCT04975698
Treatments Being Tested
RATIONALE: Photopheresis treats the patient's blood with drugs and ultravio...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-10-24
Trial ID
NCT00045305
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
Background: Blood cancers (such as leukemias or lymphomas) often do not re...
Status
Recruiting
Location
City of Hope
Start Date
2022-11-18
Trial ID
NCT05436418
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2005-01
Trial ID
NCT00301834
The purpose of this clinical trial is to evaluate the clinical and cost eff...
Status
Recruiting
Location
King's College Hospital
Start Date
2023-02-23
Trial ID
NCT05392894
Treatments Being Tested
1. To evaluate whether stem cell transplantation from a matched sibling don...
Status
Completed
Location
Graz University Hospital
Start Date
2010-04
Trial ID
NCT00606723
Treatments Being Tested
RATIONALE: Giving chemotherapy and total body irradiation before a donor bo...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-08
Trial ID
NCT00028730
This study is designed to test the ability to achieve donor hematopoietic e...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-07-11
Trial ID
NCT01626092